AdAlta Ltd (1AD) News

AdAlta Targets Sophisticated Investors With Speculative ASX-listed Options Offer

TipRanksMay 25 07:12

AdAlta Files Prospectus for Options Linked to A$2.5m Placement to Fund Solid Cancer Immunotherapy Push

TipRanksMay 25 07:11

AdAlta Hires Cell Therapy Specialists to Steer FDA Path for Mesothelioma CAR-T

TipRanksMay 25 06:48

AdAlta Showcases BZDS1901 CAR-T as Emerging Hope for Mesothelioma

TipRanksMay 11 10:27

AdAlta to Showcase Promising Mesothelioma CAR-T Data in Investor Webinar

TipRanksMay 7 08:07

AdAlta Plans Major Share and Option Issue to Expand Capital Base

TipRanksMay 4 12:07

AdAlta Shares Placed in Trading Halt Ahead of Capital Raising Announcement

TipRanksApr 30 08:25

AdAlta Launches "East-to-West" CAR-T Strategy With Promising Mesothelioma Data

TipRanksApr 30 08:18

AdAlta Taps Oribiotech's Automated Platform to Scale CAR-T Manufacturing in Asia-Pacific

TipRanksApr 21 07:29

AdAlta Reshapes Board as It Pushes East-to-West CAR-T Strategy

TipRanksApr 17 07:57

AdAlta Options Lapse, Trimming Potential Dilution

TipRanksApr 2 11:18

AdAlta's CAR-T Therapy Delivers Strong Tumour Responses in Advanced Mesothelioma Trial

TipRanksApr 1 11:07

AdAlta Secures Canadian Patent to Complete Global AD-214 Protection

TipRanksMar 20 07:09

AdAlta Adds Investor Relations Specialist Fadi Diab to Board as It Advances East-to-West Immunotherapy Strategy

TipRanksMar 18 06:37

AdAlta Appoints Fadi Diab as Director With No Initial Shareholding

TipRanksMar 18 06:37

AdAlta's AdCella Bolsters Advisory Board to Advance Armoured CAR-T Therapy BZDS1901

TipRanksMar 4 06:37

AdAlta Outlines 'East to West' Strategy to Expand CAR-T Access Across Australia and SE Asia

TipRanksFeb 4 07:09

AdAlta Completes Share and Option Issue to Sophisticated Investors

TipRanksJan 30 07:55

AdAlta Seeks ASX Quotation for New Shares and Options

TipRanksJan 30 07:54

AdAlta Seeks ASX Quotation for 240m New Shares and 120m Options

TipRanksJan 30 07:53